Characteristic | Level/unit | No–low (n = 183) | Moderate–high (n = 71) | p value | Test |
---|---|---|---|---|---|
Age at consent | Years | 60.8 (53.5–65.5) | 53.8 (45.3–64.3) | 0.001 | MU |
Time after surgery | Years | 3.0 (1.8–4.7) | 2.3 (1.7–4.0) | 0.139 | MU |
Nodes removed |  | 10.0 (5.5–15.0) | 9.0 (5.0–12.0) | 0.154 | MU |
Side of primary | Left Right | 52 (94) 48 (87) | 54 (38) 46 (32) | 0.779 | F |
Tumor grade | III II I | 24 (38) 51 (81) 26 (41) | 23 (15) 53 (34) 23 (15) | 0.930 | χ2 |
Type of surgery | Mastectomy WLE | 81 (148) 19 (34) | 72 (50) 28 (19) | 0.165 | F |
Lymph node surgery | ALND SLNB | 85 (153) 15 (28) | 78 (54) 22 (15) | 0.263 | F |
Chemotherapy | Yes No | 74 (131) 26 (46) | 84 (58) 16 (11) | 0.129 | F |
Hormonal therapy | Yes No | 77 (134) 23 (39) | 79 (54) 21 (14) | 0.863 | F |
Hormonal regimen | Tamoxifen | 62 (106) | 60 (41) | 0.238 | χ2 |
Aromatase inhibitor | 8 (14) | 4 (3) | |||
Both | 7 (12) | 15 (10) | |||
Radiotherapy | Yes No | 68 (114) 32 (53) | 74 (50) 26 (18) | 0.531 | F |